Microbe-mineral interactions in the Plastisphere: Coastal biogeochemistry and consequences for degradation of plastics

Autor: Maya S. Dodhia, Kelsey L. Rogers, Victor Fernández-Juárez, Joan A. Carreres-Calabuig, Carolin R. Löscher, Amandine A. Tisserand, Nynke Keulen, Lasse Riemann, Yvonne Shashoua, Nicole R. Posth

Publikováno v: Frontiers in Marine Science, Vol 10 (2023)

Microbe-mineral interactions, such as mineral substrate utilization and aggregate formation, have played a key role in the cycling of elements through Earth evolution. In water, soils, and sediment biogeochemistry modulates microbial community compos

Externí odkaz: https://doaj.org/article/04157f70b2cb42db8cb81f63eff432c7

Microbe-mineral interactions in the Plastisphere:Coastal biogeochemistry and consequences for degradation of plastics

Autor: Maya S. Dodhia, Kelsey L. Rogers, Victor Fernández-Juárez, Joan A. Carreres-Calabuig, Carolin R. Löscher, Amandine A. Tisserand, Nynke Keulen, Lasse Riemann, Yvonne Shashoua, Nicole R. Posth

Publikováno v: Dodhia, M S, Rogers, K L, Fernández-juárez, V, Carreres-Calabuig, J A, Löscher, C R, Tisserand, A A, Keulen, N, Riemann, L, Shashoua, Y & Posth, N R 2023, ' Microbe-mineral interactions in the Plastisphere : Coastal biogeochemistry and consequences for degradation of plastics ', Frontiers in Marine Science, vol. 10, 1134815 . https://doi.org/10.3389/fmars.2023.1134815

Microbe-mineral interactions, such as mineral substrate utilization and aggregate formation, have played a key role in the cycling of elements through Earth evolution. In water, soils, and sediment biogeochemistry modulates microbial community compos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a331bb415bc162c9a13c46e84cda7a9
https://curis.ku.dk/ws/files/340109036/fmars_10_1134815.pdf

Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.

Autor: Pecquet C; Ludwig Cancer Research, Brussels, Belgium.; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium., Papadopoulos N; Ludwig Cancer Research, Brussels, Belgium.; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium., Balligand T; Ludwig Cancer Research, Brussels, Belgium.; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium., Chachoua I; Ludwig Cancer Research, Brussels, Belgium.; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium.; Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey., Tisserand A; INSERM, Unité Mixte de Recherche (UMR) 1287, Gustave Roussy, Villejuif, France.; Université Paris Cité, UMR 1287, Gustave Roussy, Villejuif, France.; UMR 1287, Gustave Roussy, Villejuif, France., Vertenoeil G; Ludwig Cancer Research, Brussels, Belgium.; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium., Nédélec A; Ludwig Cancer Research, Brussels, Belgium.; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium., Vertommen D; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium., Roy A; Ludwig Cancer Research, Brussels, Belgium.; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium., Marty C; INSERM, Unité Mixte de Recherche (UMR) 1287, Gustave Roussy, Villejuif, France.; UMR 1287, Gustave Roussy, Villejuif, France.; Université Paris-Saclay, UMR 1287, Gustave Roussy, Villejuif, France., Nivarthi H; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Defour JP; Ludwig Cancer Research, Brussels, Belgium.; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium., El-Khoury M; INSERM, Unité Mixte de Recherche (UMR) 1287, Gustave Roussy, Villejuif, France.; UMR 1287, Gustave Roussy, Villejuif, France.; Université Paris-Saclay, UMR 1287, Gustave Roussy, Villejuif, France., Hug E; MyeloPro Diagnostics and Research GmbH, Vienna, Austria., Majoros A; MyeloPro Diagnostics and Research GmbH, Vienna, Austria., Xu E; MyeloPro Diagnostics and Research GmbH, Vienna, Austria., Zagrijtschuk O; MyeloPro Diagnostics and Research GmbH, Vienna, Austria., Fertig TE; MyeloPro Diagnostics and Research GmbH, Vienna, Austria., Marta DS; Ultrastructural Pathology Lab and Bioimaging, Institute of Pathology Victor Babeș, Bucharest, Romania., Gisslinger H; Division of Hematology and Blood Coagulation, Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria., Gisslinger B; Division of Hematology and Blood Coagulation, Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria., Schalling M; Division of Hematology and Blood Coagulation, Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria., Casetti I; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy., Rumi E; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy., Pietra D; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy., Cavalloni C; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy., Arcaini L; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy., Cazzola M; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy., Komatsu N; Department of Hematology, Graduate School of Medicine, Juntendo University, Tokyo, Japan., Kihara Y; Department of Hematology, Graduate School of Medicine, Juntendo University, Tokyo, Japan., Sunami Y; Department of Hematology, Graduate School of Medicine, Juntendo University, Tokyo, Japan., Edahiro Y; Department of Hematology, Graduate School of Medicine, Juntendo University, Tokyo, Japan., Araki M; Department of Transfusion Medicine and Stem Cell Regulation, Graduate School of Medicine, Juntendo University, Tokyo, Japan., Lesyk R; Department of Biotechnology and Cell Biology, Medical College, University of Information Technology and Management in Rzeszow, Rzeszow, Poland.; Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine., Buxhofer-Ausch V; Department of Internal Medicine I with Hematology, Ordensklinikum Linz Elisabethinen, Stem Cell Transplantation Hemostaseology and Medical Oncology, Linz, Austria.; Medical Faculty, Johannes Kepler University Linz, Linz, Austria., Heibl S; Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria., Pasquier F; INSERM, Unité Mixte de Recherche (UMR) 1287, Gustave Roussy, Villejuif, France.; Université Paris Cité, UMR 1287, Gustave Roussy, Villejuif, France.; UMR 1287, Gustave Roussy, Villejuif, France.; Department of Hematology, Gustave Roussy, Villejuif, France., Havelange V; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium.; Department of Hematology, Cliniques universitaires Saint-Luc, Brussels, Belgium., Plo I; INSERM, Unité Mixte de Recherche (UMR) 1287, Gustave Roussy, Villejuif, France.; UMR 1287, Gustave Roussy, Villejuif, France.; Université Paris-Saclay, UMR 1287, Gustave Roussy, Villejuif, France., Vainchenker W; INSERM, Unité Mixte de Recherche (UMR) 1287, Gustave Roussy, Villejuif, France.; UMR 1287, Gustave Roussy, Villejuif, France.; Université Paris-Saclay, UMR 1287, Gustave Roussy, Villejuif, France., Kralovics R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Constantinescu SN; Ludwig Cancer Research, Brussels, Belgium.; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium.; Walloon Excellence in Life Sciences and Biotechnology, Brussels, Belgium.; Ludwig Institute for Cancer Research, Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.

Publikováno v: Blood [Blood] 2023 Feb 23; Vol. 141 (8), pp. 917-929.

In Vivo Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic Target.

Autor: Murakami S; CEA-INSERM UMR1274, Institut de Radiobiologie Cellulaire et Moléculaire (iRCM), Institut de Biologie François Jacob (IBFJ), Direction de la Recherche Fondamentale (DRF), CEA, Fontenay aux Roses, France.; Université Paris Diderot, Paris, France.; Université Paris Saclay, Gif-sur-Yvette, France., Barroca V; CEA-INSERM UMR1274, Institut de Radiobiologie Cellulaire et Moléculaire (iRCM), Institut de Biologie François Jacob (IBFJ), Direction de la Recherche Fondamentale (DRF), CEA, Fontenay aux Roses, France.; Université Paris Diderot, Paris, France.; Université Paris Saclay, Gif-sur-Yvette, France., Perié L; Université Paris Diderot, Paris, France.; Université Paris Saclay, Gif-sur-Yvette, France., Bravard A; CEA-INSERM UMR1274, Institut de Radiobiologie Cellulaire et Moléculaire (iRCM), Institut de Biologie François Jacob (IBFJ), Direction de la Recherche Fondamentale (DRF), CEA, Fontenay aux Roses, France.; Université Paris Diderot, Paris, France.; Université Paris Saclay, Gif-sur-Yvette, France., Bernardino-Sgherri J; CEA-INSERM UMR1274, Institut de Radiobiologie Cellulaire et Moléculaire (iRCM), Institut de Biologie François Jacob (IBFJ), Direction de la Recherche Fondamentale (DRF), CEA, Fontenay aux Roses, France.; Université Paris Diderot, Paris, France.; Université Paris Saclay, Gif-sur-Yvette, France., Tisserand A; Institut Curie, PSL Research University, CNRS UMR168, Paris, France., Devanand C; CEA-INSERM UMR1274, Institut de Radiobiologie Cellulaire et Moléculaire (iRCM), Institut de Biologie François Jacob (IBFJ), Direction de la Recherche Fondamentale (DRF), CEA, Fontenay aux Roses, France.; Université Paris Diderot, Paris, France.; Université Paris Saclay, Gif-sur-Yvette, France., Edmond V; Institut Curie, PSL Research University, CNRS UMR168, Paris, France., Magniez A; Université Paris Diderot, Paris, France.; Université Paris Saclay, Gif-sur-Yvette, France., Tenreira Bento S; Université Paris Diderot, Paris, France.; Université Paris Saclay, Gif-sur-Yvette, France., Torres C; CEA-INSERM UMR1274, Institut de Radiobiologie Cellulaire et Moléculaire (iRCM), Institut de Biologie François Jacob (IBFJ), Direction de la Recherche Fondamentale (DRF), CEA, Fontenay aux Roses, France.; Université Paris Diderot, Paris, France.; Université Paris Saclay, Gif-sur-Yvette, France., Pasquier F; Sorbonne Universités, UPMC Univ Paris 06, France., Plo I; Institut Curie, PSL Research University, CNRS UMR168, Paris, France., Vainchenker W; Institut Curie, PSL Research University, CNRS UMR168, Paris, France., Villeval JL; Institut Curie, PSL Research University, CNRS UMR168, Paris, France., Roméo PH; CEA-INSERM UMR1274, Institut de Radiobiologie Cellulaire et Moléculaire (iRCM), Institut de Biologie François Jacob (IBFJ), Direction de la Recherche Fondamentale (DRF), CEA, Fontenay aux Roses, France.; Université Paris Diderot, Paris, France.; Université Paris Saclay, Gif-sur-Yvette, France., Lewandowski D; CEA-INSERM UMR1274, Institut de Radiobiologie Cellulaire et Moléculaire (iRCM), Institut de Biologie François Jacob (IBFJ), Direction de la Recherche Fondamentale (DRF), CEA, Fontenay aux Roses, France.; Université Paris Diderot, Paris, France.; Université Paris Saclay, Gif-sur-Yvette, France.

Publikováno v: Blood cancer discovery [Blood Cancer Discov] 2022 Jul 06; Vol. 3 (4), pp. 285-297.

Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasms.

Autor: El-Khoury M; INSERM, UMR1287, Villejuif, France.; Gustave Roussy, Villejuif, France.; Université Paris Diderot (Paris 7), UMR1287, Gustave Roussy, Villejuif, France., Cabagnols X; INSERM, UMR1287, Villejuif, France.; Gustave Roussy, Villejuif, France.; Université Paris Diderot (Paris 7), UMR1287, Gustave Roussy, Villejuif, France., Mosca M; INSERM, UMR1287, Villejuif, France.; Gustave Roussy, Villejuif, France.; Université Paris XI, UMR1287, Gustave Roussy, Villejuif, France., Vertenoeil G; Ludwig Institute for Cancer Research Brussels, Brussels, Belgium.; Université Catholique de Louvain and de Duve Institute, Brussels, Belgium., Marzac C; Département d'Hématologie, Gustave Roussy, Villejuif, France., Favale F; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, UMR_S 938, Paris, France., Bluteau O; INSERM, UMR1287, Villejuif, France.; Gustave Roussy, Villejuif, France.; Université Paris XI, UMR1287, Gustave Roussy, Villejuif, France., Lorre F; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, UMR_S 938, Paris, France., Tisserand A; INSERM, UMR1287, Villejuif, France.; Gustave Roussy, Villejuif, France.; Université Paris Diderot (Paris 7), UMR1287, Gustave Roussy, Villejuif, France., Rabadan Moraes G; INSERM, UMR1287, Villejuif, France.; Gustave Roussy, Villejuif, France.; Université Paris Diderot (Paris 7), UMR1287, Gustave Roussy, Villejuif, France., Ugo V; CHU Angers, Laboratoire d'Hématologie, Angers, France., Ianotto JC; CHRU Brest, service d'Hématologie, Brest, France., Rey J; Département d'Hématologie, Institut Paoli Calmettes, Service d'Hématologie, Marseille, France., Solary E; INSERM, UMR1287, Villejuif, France.; Gustave Roussy, Villejuif, France.; Université Paris XI, UMR1287, Gustave Roussy, Villejuif, France.; Département d'Hématologie, Gustave Roussy, Villejuif, France., Roy L; Assistance Publique Hôpitaux de Paris, CHU Henri Mondor, Service d'Hématologie, Créteil, France., Rameau P; Gustave Roussy, Villejuif, France., Debili N; INSERM, UMR1287, Villejuif, France.; Gustave Roussy, Villejuif, France.; Université Paris XI, UMR1287, Gustave Roussy, Villejuif, France., Pasquier F; INSERM, UMR1287, Villejuif, France.; Gustave Roussy, Villejuif, France.; Université Paris XI, UMR1287, Gustave Roussy, Villejuif, France.; Département d'Hématologie, Gustave Roussy, Villejuif, France., Casadevall N; INSERM, UMR1287, Villejuif, France.; Gustave Roussy, Villejuif, France.; Laboratoire d'Hématologie, Hôpital Saint Antoine, Assistance Publique Hôpitaux de Paris, Paris, France., Marty C; INSERM, UMR1287, Villejuif, France.; Gustave Roussy, Villejuif, France.; Université Paris XI, UMR1287, Gustave Roussy, Villejuif, France., Constantinescu SN; Ludwig Institute for Cancer Research Brussels, Brussels, Belgium.; Université Catholique de Louvain and de Duve Institute, Brussels, Belgium.; WELBIO (Walloon Excellence in Life Sciences and Biotechnology), Brussels, Belgium., Raslova H; INSERM, UMR1287, Villejuif, France.; Gustave Roussy, Villejuif, France.; Université Paris XI, UMR1287, Gustave Roussy, Villejuif, France., Vainchenker W; INSERM, UMR1287, Villejuif, France. william.vainchenker@gustaveroussy.fr.; Gustave Roussy, Villejuif, France. william.vainchenker@gustaveroussy.fr.; Université Paris XI, UMR1287, Gustave Roussy, Villejuif, France. william.vainchenker@gustaveroussy.fr., Plo I; INSERM, UMR1287, Villejuif, France. isabelle.plo@gustaveroussy.fr.; Gustave Roussy, Villejuif, France. isabelle.plo@gustaveroussy.fr.; Université Paris XI, UMR1287, Gustave Roussy, Villejuif, France. isabelle.plo@gustaveroussy.fr.

Publikováno v: Oncogene [Oncogene] 2020 Jul; Vol. 39 (31), pp. 5323-5337. Date of Electronic Publication: 2020 Jun 22.